retatrutide trial phase Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released 2 results demonstrating 25% weight loss in half of people with #obesity. This amount of weight loss has not been accomplished Retatrutide FDA Approval Status 2026:

The FDA uses vitamin C (ascorbic acid) as an example to explain that: it can come from an orange or be produced in a laboratory the end molecule is the same

Molecular Formula: CHNO (base peptide)

Today is actually shot day & the start of my 4th week on the medication

If youre looking for FDA-approved medication covered by insurance, Ro is one of the best GLP-1 suppliers

Passos, P

Dysbiosis during this transition underlies elevated ketosis risk: the decline of VFA-producing taxaincluding Ruminococcus , Prevotella , Selenomonas , and Succinivibrionaceaeimpairs propionate fermentation pathways and reduces gluconeogenic precursor supply, while the concurrent expansion of opportunistic taxa such as Mycoplasma and Saccharimonas further destabilizes ruminal homeostasis (Table 2), collectively contributing to hypoglycemia, excessive mobilization of body fat, and ketone accumulation, which compromise lactation, reproductive performance, and offspring health 47,55,56,57